Evergreen Quality Fund GP, Ltd.

Position in ERAS — Erasca, Inc.

CIK 2016939 GRAND CAYMAN, E9

Position in ERAS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,195,496

New position

Shares Held

1,375,300

first reported quarter

Ownership

0.393%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#37

of 255 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Evergreen Quality Fund GP, Ltd. holds $47,525,100 across 3 Biotechnology names. ERAS ranks #1 (53.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc. This page	1,375,300	$25,195,496
2	FDMT	4D Molecular Therapeutics, Inc.	951,474	$12,654,604
3	COGT	Cogent Biosciences, Inc.	250,000	$9,675,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,195,496	1,375,300	—	Shares	Other	2026-08-14
No filing history on record for this holder in this stock.